Central banks

A cost/benefit approach to Basel II

The cost of implementing Basel II could put banks at a competitive disadvantage compared with non-banks, and spur them to ‘de-bank’ to avoid this regulatory burden. Harry Stordel and Andrew Cross say regulators must look at the provisions from a cost…

EU bank regulation debate intensifies

The debate over banking supervision in the European Union intensified in April as Britain and Germany argued for keeping regulation under the aegis of national regulators, while many central bankers argued that the role should be left to the European…

A cost/benefit approach to Basel II

The cost of implementing Basel II could put banks at a competitive disadvantage compared with non-banks, and spur them to ‘de-bank’ to avoid this regulatory burden. Harry Stordel and Andrew Cross say regulators must look at the provisions from a cost…

The benefits of Enron

Many corporations are keeping a low profile when it comes to their derivatives use. But when the Enron-related witch-hunts are over, companies may find that insurers and shareholders now view corporate hedging as a fiduciary duty

OTC derivatives volumes up 11%, says BIS

Outstanding notional volumes for the over-the-counter derivatives market stood at $111 trillion at end-December 2001 – an 11% increase from the end of June 2001, according to the latest statistics released by the Bank for International Settlements (BIS).

Revamping Corporate Actions

Dividend payments, stock splits, name changes, spin-offs and other corporate actions impacting securities already held in accounts were not supposed to be affected by T+1. But as the deadline for shortening the trade settlement cycle is challenging firms…

Gaining an edge from Basel

The recent recommendations of the Basel Committee are set to usher in a period of upheaval for many participants in the banking sector. Standard & Poor’s Anthony Albert looks at how to gain a competitive advantage in credit risk management in the light…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here